Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Partial agonist activity at PPARdelta (unknown origin) assessed as increase in fluorescein labeled PRIP/RAP250 coactivator peptide requirement by Lanthascreen TR-FRET assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Partial agonist activity at PPARdelta (unknown origin) assessed as increase in fluorescein labeled SMRT corepressor peptide requirement by Lanthascreen TR-FRET assay
Assay data:2 Tested
SummaryPubMed CitationRelated BioAssays by Target
Partial agonist activity at PPARalpha (unknown origin) assessed as increase in fluorescein labeled SMRT corepressor peptide requirement by Lanthascreen TR-FRET assay
Partial agonist activity at PPARgamma (unknown origin) assessed as increase in fluorescein labeled SMRT corepressor peptide requirement by Lanthascreen TR-FRET assay
Partial agonist activity at PPARgamma (unknown origin) assessed as increase in fluorescein labeled SRC-2 coactivator peptide requirement by Lanthascreen TR-FRET assay
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Partial agonist activity at PPARgamma (unknown origin) assessed as increase in fluorescein labeled SRC-1 coactivator peptide requirement by Lanthascreen TR-FRET assay
Partial agonist activity at PPARgamma (unknown origin) assessed as increase in fluorescein labeled PRIP/RAP250 coactivator peptide requirement by Lanthascreen TR-FRET assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 4 Tested
Partial agonist activity at PPARalpha (unknown origin) assessed as increase in PRIP/RAP250 coactivator peptide requirement by Lanthascreen TR-FRET assay
Partial agonist activity at PPARgamma in human BMMSC cells assessed as inhibition of pioglitazone-induced adiponectin synthesis measured after 5 days by ELISA
Binding affinity to PPARdelta (unknown origin) assessed as inhibition constant by Cheng-Prusoff equation analysis
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 4 Tested
Binding affinity to PPARgamma (unknown origin) assessed as inhibition constant by Cheng-Prusoff equation analysis
Assay data:3 Active, 2 Activity ≤ 1 µM, 4 Tested
Binding affinity to PPARalpha (unknown origin) assessed as inhibition constant by Cheng-Prusoff equation analysis
Displacement of fluormone pan-PPARgreen from PPARdelta (unknown origin) at 30 uM by TR-FRET based competitive binding assay relative to control
Displacement of fluormone pan-PPARgreen from PPARgamma (unknown origin) at 30 uM by TR-FRET based competitive binding assay relative to control
Displacement of fluormone pan-PPARgreen from PPARalpha (unknown origin) at 30 uM by TR-FRET based competitive binding assay relative to control
Selectivity interaction (Enzyme panel (Eurofins-Cerep)) EUB0000262b PPARG
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (CEREP panel (Eurofins, binding assay)) EUB0000262b PPARG
Selectivity interaction (Enzymatic assay (PanLabs Profiling)) EUB0000715a PPARG
Inhibition of recombinant human PPAR gamma NHR incubated for 120 mins by scintillation counting based radiometry assay
Agonist activity at PPAR-gamma LBD (unknown origin) using Texas red-labeled DRIP-2 as substrate upto 100 uM incubated for 2 hrs by fluorescence polarization assay
Assay data:3 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on